61 results
8-K
EX-99.1
CDTX
Cidara Therapeutics Inc
3 May 24
Other Events
8:00am
safety, efficacy and PK objectives Coverage of diverse panels of seasonal and pandemic strains1 Single SQ or IM dose per flu season Streamlined, low … n i v e r s a l ” p r e v e n t i o n a n d t r e a t m e n t Potent in-vitro and in-vivo activity against all tested seasonal and pandemic strains
8-K/A
EX-2.1
CDTX
Cidara Therapeutics Inc
29 Apr 24
Entry into a Material Definitive Agreement
4:57pm
of, a pandemic, epidemic or disease outbreak or other public health conditions), force-majeure events or other comparable events (or, in each case, the exercise
8-K
EX-99.1
CDTX
Cidara Therapeutics Inc
6 Sep 23
Cidara Therapeutics Announces Janssen’s Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza
8:05am
seasonal and pandemic influenza strains A and B. This milestone payment, in addition to potential future milestone payments, if achieved, will provide … effects, and impacts of the COVID-19 pandemic or other obstacles on the enrollment of patients or other aspects of CD388 development. These and other risks
8-K
EX-99.1
b2e8uamir gg
11 May 23
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
9mrvzz
3 Nov 22
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
5:30pm
PRE 14A
7zmnqh6 oj6k53drsm
31 Oct 22
Preliminary proxy
5:28pm
8-K
EX-99.1
2qtfymucgqp2yt3l6
11 May 22
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:08pm
8-K
EX-99.1
nm18yj9d6p9iz
7 Mar 22
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
5:15pm
8-K
EX-99.1
6t6u8qyeeb ttd1l9d
14 Dec 21
Regulation FD Disclosure
7:05am
8-K
EX-99.2
r1vk8bcwtn2d0di7i986
14 Dec 21
Regulation FD Disclosure
7:05am